agilon health Inc
$ 102.16
7.16%
09 Jun - close price
- Market Cap 1,615,825,000 USD
- Current Price $ 102.16
- High / Low $ 104.55 / 94.25
- Stock P/E N/A
- Book Value 10.93
- EPS -22.59
- Next Earning Report 2026-08-03
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.14 %
- ROE -1.10 %
- 52 Week High 104.55
- 52 Week Low 7.48
About
agilon health, inc. The company is headquartered in Long Beach, California.
Analyst Target Price
$60.36
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-06 | 2026-02-25 | 2025-11-04 | 2025-08-04 | 2025-05-06 | 2025-02-25 | 2024-11-07 | 2024-08-05 | 2024-05-07 | 2024-02-27 | 2023-11-02 | 2023-08-03 |
| Reported EPS | 1.14 | -0.358 | -6.75 | -6.25 | 0.75 | -0.25 | -6.98 | -1.81 | -0.16 | -0.41 | -2 | -1 |
| Estimated EPS | 0.83 | -0.2719 | -4.11 | -2.93 | -0.29 | -0.128 | -2.14 | -1.46 | -0.25 | -0.3 | -1.55 | -0.03 |
| Surprise | 0.31 | -0.0861 | -2.64 | -3.32 | 1.04 | -0.122 | -4.84 | -0.35 | 0.09 | -0.11 | -0.45 | -0.97 |
| Surprise Percentage | 37.3494% | -31.6661% | -64.2336% | -113.3106% | 358.6207% | -95.3125% | -226.1682% | -23.9726% | 36% | -36.6667% | -29.0323% | -3233.3333% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-03 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.47 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AGL
2026-06-08 10:04:22
Agilon Health Inc (AGL) has seen a dramatic surge in its share price in 2026, making it one of the year's top performers on the US market with a gain of over 400% and a market capitalization around USD 1.6 billion. The company operates a value-based primary care platform, partnering with physician groups to manage senior care, particularly Medicare Advantage populations, and generates revenue primarily through capitated arrangements with health plans. Its success is driven by managing medical costs effectively, expanding membership, and optimizing medical margins, though future performance will depend on consistent profitability and navigating regulatory and industry dynamics.
2026-06-06 00:08:58
agilon health's Chief Legal Officer, Denise Zamore, reported a tax-related disposition of 485 shares. These shares were withheld by the company to cover income tax obligations stemming from the net settlement of restricted stock units and do not represent an open-market sale. Following this transaction, Zamore directly holds 66,112 shares, including restricted stock units.
2026-06-05 23:09:06
Agilon health (AGL) is experiencing renewed investor interest due to a significant valuation gap highlighted by analysts, alongside a sharp share price rebound post-reverse split. However, this positive sentiment is tempered by concerns about leadership turnover, execution risks, ongoing securities lawsuits, and potential issues with medical cost control, particularly with a new CEO at the helm. The article suggests that despite the apparent undervaluation, these governance and operational challenges present significant short-term risks and catalysts for the company.
2026-06-05 11:40:01
Agilon health, inc. (NYSE: AGL) announced strong first-quarter 2026 results, reporting total revenue of $1.42 billion and significantly increased net income of $49 million compared to the previous year. The company also raised its full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA, attributing the performance to disciplined execution and strategic investments. Ronald A. Williams, Executive Chairman, highlighted progress in clinical execution and operating discipline, and welcomed Tim O'Rourke as the new CEO to further sharpen the focus on execution and stakeholder value.
2026-06-05 01:39:09
agilon health director John William Wulf was granted 2,133 restricted stock units as compensation, which will vest in full on June 2, 2027, subject to his continued service. Following this grant, his beneficial ownership of agilon health shares, including RSUs, stands at 16,765, adjusted for a 1-for-25 reverse stock split effective March 30, 2026. This transaction reflects an equity award rather than an open-market stock purchase.
2026-06-05 01:39:09
agilon health director Silvana Battaglia received an equity award of 2,133 restricted stock units (RSUs) on June 2, 2026, as reported in a Form 4 filing. These RSUs, granted at no cash cost, will vest in full on June 2, 2027, contingent upon her continued service as a director. Following this grant, her beneficial ownership stands at 7,926 shares, reflecting a 1-for-25 reverse stock split that became effective on March 30, 2026.
